Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 10 Sept, 01:30 am
Top Stock Gainers: CEA Industries Inc. (NASDAQ: BNC) Leads Market Surge CEA Industries Inc. (NASDAQ: BNC) surged 50.7% amid attention surrounding the launch of BNC4. Swvl Holdings Corp. (NASDAQ: SWVL) gained 30.8% after HSBC expanded its working-capital facility. Wing Yip Food Ho
Pharvaris's experimental oral drug, deucrictibant, achieved an 83% reduction in hereditary angioedema (HAE) attack rates in its CHAPTER-3 Phase 3 study. Analyst firm Oppenheimer significantly increased its price target for Pharvaris to $75.00 from $50.00 , reaffirming an "Outperf
Inhibrx Biosciences, Inc. (NASDAQ: INBX) CEO demonstrated strong confidence with a significant insider purchase of shares. The company announced positive Phase 2 HexAgon study results for its cancer drug candidate , INBRX-106, showing superior efficacy when combined with Keytruda
Chewy (NYSE: CHWY) Upcoming Earnings Preview: Key Metrics and Growth Drivers Chewy (NYSE: CHWY) is set to announce its quarterly earnings on September 9, 2026, with analysts closely watching its performance in the competitive online pet retail market. Earnings per share (EPS) are
Analyst firm Jefferies raised its price target for Tarsus Pharmaceuticals to $105.00 , indicating a potential upside of 17.1% . Tarsus Pharmaceuticals (NASDAQ: TARS) recently acquired Alkeus Pharmaceuticals, expanding its drug pipeline with worldwide rights to gildeuretinol for S
Analyst Mark Mahaney raised the price target for The Trade Desk to $14.00 , with the stock trading slightly above this new target. The Trade Desk faces an S&P 500 index removal, which led to a 2% stock decline, alongside a restructuring plan involving a 15% workforce reduction. D
GameStop (NYSE: GME) reported Q2 2026 revenue of $790.20 million , surpassing analyst estimates, though total revenue saw a year-over-year decrease. The Collectibles segment demonstrated significant growth, increasing 57% year-over-year to $356.30 million , while Video Games reve
Analyst Michael Freeman from Raymond James has set a new price target of $37 for Dyne Therapeutics (NASDAQ: DYN) , indicating a significant potential upside for the clinical-stage biotechnology company. Dyne Therapeutics is actively advancing its clinical pipeline, with upcoming
17 Education & Technology Group Inc. (NASDAQ: YQ) is set to release its quarterly earnings with analysts forecasting a negative EPS of -$8.60 and revenue of $73.47 million . Despite a history of unprofitability, indicated by a P/E ratio of -1.82 and an earnings yield of -52.40% ,
An analyst from Jefferies recently raised the price target for Roivant Sciences to $52 , suggesting a potential upside of 24.7% . Pulmovant, a Roivant company, announced strong Phase 2 clinical trial results for mosliciguat, showing a significant 56.3% reduction in pulmonary vasc
EVI Industries reported robust Q4 revenue of $121.87 million , exceeding analyst expectations. The company achieved a record fiscal year revenue of $446.6 million , representing a significant 15% increase year-over-year. Earnings per share (EPS) of $0.17 met analyst forecasts, wi
Despite recent unprofitability and a negative EPS forecast, Lakeland Industries, Inc. (NASDAQ:LAKE) continues to secure significant contracts, including deals with the Hong Kong Government Flying Service and Airports of Thailand. Analysts project a negative earnings per share (EP
Analyst Expectations: Wall Street anticipates Mission Produce to report earnings per share (EPS) of $0.12 and revenue of approximately $367.58 million for Q3 2026. Peruvian Output Boost: A projected record output of 120-130 million pounds of avocados from Peru is expected to impr
Analyst Outlook: Despite a lowered price target from Deutsche Bank, Planet Labs (NYSE:PL) still shows a potential 57.57% upside, reflecting ongoing investor interest in the aerospace and defense industry . Strong Q2 Financial Performance: The company reported record revenue of $1
Intel (NASDAQ: INTC) Stock Surges on High-NA EUV Progress and Analyst Upgrade Intel shares rose sharply after the company announced further progress in using High-NA EUV technology in high-volume manufacturing. Northland Securities upgraded Intel from “Market Perform”
ABM Industries surpassed analyst EPS estimates with strong quarterly earnings, reporting $1.04 per share. The company achieved record revenue of $2.3 billion , marking a 4.2% increase, and a 19% rise in adjusted net income. ABM demonstrated robust cash generation with $146.8 mill
GameStop's upcoming earnings report on September 8, 2026, is highly anticipated, with analysts projecting an EPS of $0.27 and revenues of $756.85 million . The company's preliminary net sales projection of $780 million to $800 million indicates a significant year-over-year decrea
Opus Genetics, Inc. (NASDAQ: IRD): Analyst Price Target and Upcoming Gene-Therapy Data Opus Genetics, Inc. (NASDAQ: IRD) is a clinical-stage biopharmaceutical company developing therapies for inherited retinal diseases and other eye disorders. H.C. Wainwright analyst Matthew Cauf
Headlines provided by Investing.com